| Literature DB >> 26577044 |
Melissa Hill1, Jo-Ann Johnson2, Sylvie Langlois3, Hyun Lee3, Stephanie Winsor4, Brigid Dineley4, Marisa Horniachek4, Faustina Lalatta5, Luisa Ronzoni5, Angela N Barrett6, Henna V Advani6, Mahesh Choolani6, Ron Rabinowitz7, Eva Pajkrt8, Rachèl V van Schendel9, Lidewij Henneman9, Wieke Rommers10, Caterina M Bilardo10, Paula Rendeiro11, Maria João Ribeiro12, José Rocha11,12, Ida Charlotte Bay Lund13, Olav B Petersen14, Naja Becher14, Ida Vogel14, Vigdis Stefánsdottir15, Sigrun Ingvarsdottir16,17, Helga Gottfredsdottir16,17, Stephen Morris18, Lyn S Chitty1.
Abstract
Non-invasive prenatal testing is increasingly available worldwide and stakeholder viewpoints are essential to guide implementation. Here we compare the preferences of women and health professionals from nine different countries towards attributes of non-invasive and invasive prenatal tests for Down syndrome. A discrete choice experiment was used to obtain participants' stated preference for prenatal tests that varied according to four attributes: accuracy, time of test, risk of miscarriage, and type of information. Pregnant women and health professionals were recruited from Canada, Denmark, Iceland, Israel, Italy, the Netherlands, Portugal, Singapore, and the United Kingdom. A total of 2666 women's and 1245 health professionals' questionnaires were included in the analysis. Differences in preferences were seen between women and health professionals within and between countries. Overall, women placed greater emphasis on test safety and comprehensive information than health professionals, who emphasised accuracy and early testing. Differences between women's and health professionals' preferences are marked between countries. Varied approaches to implementation and service delivery are therefore needed and individual countries should develop guidelines appropriate for their own social and screening contexts.Entities:
Mesh:
Year: 2015 PMID: 26577044 PMCID: PMC5070900 DOI: 10.1038/ejhg.2015.249
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246